Patriot Scientific Corporation Announces Varian Medical Systems Purchase of a Moore Microprocessor Patent(TM) (MMP) Portfolio License

CARLSBAD, Calif.--(BUSINESS WIRE)--Patriot Scientific Corporation (OTCBB: PTSC) announced today that Varian Medical Systems (NYSE: VAR) has purchased a Moore Microprocessor Patent™ Portfolio license from The TPL Group, Patriot Scientific’s exclusive MMP™ Portfolio licensing partner. Varian Medical Systems manufactures medical devices and software for treating cancer with radiation therapy.
MORE ON THIS TOPIC